agilon health Reports First Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
agilon health Inc (AGL) PT Raised to $43 at BofA Securities
May 27, 2021 8:26 AM EDTBofA Securities analyst Kevin Fischbeck raised the price target on agilon health Inc (NYSE: AGL) to $43.00 (from $41.00) while maintaining a Buy rating.
Raising ests as strong Q1 should flow through... MoreAgilon Health Inc. (AGL) Reports Q1 Loss of $0.04, Revenues Beat
May 26, 2021 4:34 PM EDTAgilon Health Inc. (NYSE: AGL) reported Q1 EPS of ($0.04), versus ($0.02) reported last year. Revenue for the quarter came in at $413.1 million, versus $291.05 million reported last year.
First Quarter 2021 Results:
Total revenue of $413 million increased 42% from 2020 and would have increased approximately 50% including a recently completed group Medicare Advantage (MA) contract that is retroactive to January... More